RadNet, Inc. Common Stock (RDNT) is a publicly traded Healthcare sector company. As of July 22, 2026, RDNT trades at $61.00 with a market cap of $4.77B and a P/E ratio of -342.50. RDNT moved -1.49% today. Year to date, RDNT is -13.29%; over the trailing twelve months it is +6.78%. Its 52-week range spans $45.00 to $85.84. Analyst consensus is strong buy with an average price target of $85.00. Rallies surfaces RDNT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for RDNT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $61.00 |
| Market Cap | $4.77B |
| P/E Ratio | -342.50 |
| EPS | $-0.18 |
| Dividend Yield | 0.00% |
| 52-Week High | $85.84 |
| 52-Week Low | $45.00 |
| Volume | 57.51K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.14B |
| Net Income | $22.05M |
| Gross Margin | 0.00% |
5 analysts cover RDNT: 0 strong buy, 5 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $85.00.